Introduction to Versus Zoledronic

Sentence Examples

Discover more insights into Versus Zoledronic

Keywords frequently search together with Versus Zoledronic

Narrow sentence examples with built-in keyword filters

Versus Zoledronic sentence examples within versus zoledronic acid

versus zoledronic acid

(2018) Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.

Comments on pre‐fibrotic myelofibrosis and how should it be managed

versus zoledronic acid

There was no significant improvement in OS with the addition of bisphosphonates in the major subgroup analyses (metastatic (M1) versus non-metastatic, clodronate versus zoledronic acid, castration-sensitive prostate cancer (CSPC) versus castration-refractory prostate cancer).

Effect of bisphosphonates on overall survival in subgroups of patients with prostate cancer

More versus zoledronic acid sentences More Sentences

More Versus Zoledronic sentence examples
10.1111/bjh.15840

(2018) Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.

Comments on pre‐fibrotic myelofibrosis and how should it be managed

More Versus Zoledronic sentence examples
10.1007/s10585-019-09963-4

There was no significant improvement in OS with the addition of bisphosphonates in the major subgroup analyses (metastatic (M1) versus non-metastatic, clodronate versus zoledronic acid, castration-sensitive prostate cancer (CSPC) versus castration-refractory prostate cancer).

Effect of bisphosphonates on overall survival in subgroups of patients with prostate cancer

Learn more from Versus Zoledronic

Keywords related to Versus

Versus Zoledronic
Encyclopedia

What is/are Versus Zoledronic?

Versus Zoledronic - (2018) Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. [1] There was no significant improvement in OS with the addition of bisphosphonates in the major subgroup analyses (metastatic (M1) versus non-metastatic, clodronate versus zoledronic acid, castration-sensitive prostate cancer (CSPC) versus castration-refractory prostate cancer). [2]

versus zoledronic acid

(2018) Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. [1] There was no significant improvement in OS with the addition of bisphosphonates in the major subgroup analyses (metastatic (M1) versus non-metastatic, clodronate versus zoledronic acid, castration-sensitive prostate cancer (CSPC) versus castration-refractory prostate cancer). [2]